在2019冠状病毒病大流行之前和期间,欧洲儿童、青少年和青壮年抗抑郁药使用情况的变化:系统综述

IF 4.9 2区 医学 Q1 PEDIATRICS
Alexander M Fassmer, Kathrin Wandscher, Aida Bedri, Kathrin Jobski, Luise Poustka, Christian J Bachmann, Falk Hoffmann
{"title":"在2019冠状病毒病大流行之前和期间,欧洲儿童、青少年和青壮年抗抑郁药使用情况的变化:系统综述","authors":"Alexander M Fassmer, Kathrin Wandscher, Aida Bedri, Kathrin Jobski, Luise Poustka, Christian J Bachmann, Falk Hoffmann","doi":"10.1007/s00787-025-02839-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In recent decades, antidepressant utilization among young persons in Western countries has increased, raising concerns about overprescribing and safety. The COVID-19 pandemic and respective restrictions might have impacted not only youth's mental health but also antidepressant prescribing. Our aim was to systematically investigate changes in antidepressant utilization during the pandemic compared to pre-pandemic periods in European young persons.</p><p><strong>Methods: </strong>This systematic review was registered in PROSPERO (CRD42024559951). Observational studies with ≥ 100 European young persons (0-24 years) reporting prevalence or incidence data in antidepressant utilization before and during the pandemic (2018/2019 vs. 2021/2022) were included and percentage changes between two time periods calculated. MEDLINE (via PubMed), PsycINFO, and EMBASE were searched from January 1, 2021 to July 3, 2024 and supplemented by citation searching. Study quality was assessed using the Joanna Briggs Institute's tool.</p><p><strong>Findings: </strong>We screened 4,416 records for eligibility and included eight studies covering data from Austria, Denmark, Finland, France, Italy, Norway, Spain, and Sweden (n = 4 from Nordic countries). The number of included young persons ranged from 1071 to 3,455,521 and all studies used secondary data, mostly from registries. All studies showed a relative increase in overall antidepressant use during the COVID-19 pandemic, with variability between countries ranging from 23 to 52%. Antidepressant utilization showed higher increases in adolescents (n = 3 studies) and females (n = 3 studies). Selective serotonin reuptake inhibitors were more common (73.9-90.9%; n = 3 studies) than other antidepressant classes.</p><p><strong>Interpretation: </strong>During the COVID-19 pandemic, antidepressant utilization in young persons increased modestly in all studied European countries. This increase may mirror the surge in mental health problems in young persons during the pandemic, but may also reflect altered patterns of mental health services availability.</p>","PeriodicalId":11856,"journal":{"name":"European Child & Adolescent Psychiatry","volume":" ","pages":""},"PeriodicalIF":4.9000,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Change of antidepressant utilization in children, adolescents and young adults in Europe before and during the COVID-19 pandemic: a systematic review.\",\"authors\":\"Alexander M Fassmer, Kathrin Wandscher, Aida Bedri, Kathrin Jobski, Luise Poustka, Christian J Bachmann, Falk Hoffmann\",\"doi\":\"10.1007/s00787-025-02839-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>In recent decades, antidepressant utilization among young persons in Western countries has increased, raising concerns about overprescribing and safety. The COVID-19 pandemic and respective restrictions might have impacted not only youth's mental health but also antidepressant prescribing. Our aim was to systematically investigate changes in antidepressant utilization during the pandemic compared to pre-pandemic periods in European young persons.</p><p><strong>Methods: </strong>This systematic review was registered in PROSPERO (CRD42024559951). Observational studies with ≥ 100 European young persons (0-24 years) reporting prevalence or incidence data in antidepressant utilization before and during the pandemic (2018/2019 vs. 2021/2022) were included and percentage changes between two time periods calculated. MEDLINE (via PubMed), PsycINFO, and EMBASE were searched from January 1, 2021 to July 3, 2024 and supplemented by citation searching. Study quality was assessed using the Joanna Briggs Institute's tool.</p><p><strong>Findings: </strong>We screened 4,416 records for eligibility and included eight studies covering data from Austria, Denmark, Finland, France, Italy, Norway, Spain, and Sweden (n = 4 from Nordic countries). The number of included young persons ranged from 1071 to 3,455,521 and all studies used secondary data, mostly from registries. All studies showed a relative increase in overall antidepressant use during the COVID-19 pandemic, with variability between countries ranging from 23 to 52%. Antidepressant utilization showed higher increases in adolescents (n = 3 studies) and females (n = 3 studies). Selective serotonin reuptake inhibitors were more common (73.9-90.9%; n = 3 studies) than other antidepressant classes.</p><p><strong>Interpretation: </strong>During the COVID-19 pandemic, antidepressant utilization in young persons increased modestly in all studied European countries. This increase may mirror the surge in mental health problems in young persons during the pandemic, but may also reflect altered patterns of mental health services availability.</p>\",\"PeriodicalId\":11856,\"journal\":{\"name\":\"European Child & Adolescent Psychiatry\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":4.9000,\"publicationDate\":\"2025-08-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Child & Adolescent Psychiatry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00787-025-02839-x\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PEDIATRICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Child & Adolescent Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00787-025-02839-x","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

摘要

背景:近几十年来,西方国家年轻人使用抗抑郁药的情况有所增加,这引起了人们对过度处方和安全性的担忧。COVID-19大流行和相应的限制可能不仅影响了青少年的心理健康,也影响了抗抑郁药的处方。我们的目的是系统地调查欧洲年轻人在大流行期间与大流行前相比抗抑郁药使用的变化。方法:本系统评价在PROSPERO注册(CRD42024559951)。纳入了≥100名欧洲年轻人(0-24岁)报告大流行前和大流行期间(2018/2019 vs. 2021/2022)抗抑郁药使用患病率或发病率数据的观察性研究,并计算了两个时间段之间的百分比变化。检索时间为2021年1月1日至2024年7月3日,检索时间为MEDLINE(通过PubMed)、PsycINFO和EMBASE,并辅以引文检索。使用乔安娜布里格斯研究所的工具评估研究质量。研究结果:我们筛选了4416条合格记录,并纳入了8项研究,涵盖了来自奥地利、丹麦、芬兰、法国、意大利、挪威、西班牙和瑞典的数据(n = 4来自北欧国家)。纳入的年轻人数量从1071人到3455521人不等,所有研究都使用了次要数据,主要来自登记处。所有研究都表明,在2019冠状病毒病大流行期间,抗抑郁药的总体使用相对增加,各国之间的差异从23%到52%不等。抗抑郁药物的使用在青少年(n = 3项研究)和女性(n = 3项研究)中增加较多。选择性血清素再摄取抑制剂更为常见(73.9% ~ 90.9%;N = 3项研究)比其他抗抑郁药类别。解释:在2019冠状病毒病大流行期间,在所研究的所有欧洲国家中,年轻人使用抗抑郁药的人数略有增加。这一增长可能反映了大流行期间年轻人心理健康问题的激增,但也可能反映了提供心理健康服务的模式发生了变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Change of antidepressant utilization in children, adolescents and young adults in Europe before and during the COVID-19 pandemic: a systematic review.

Background: In recent decades, antidepressant utilization among young persons in Western countries has increased, raising concerns about overprescribing and safety. The COVID-19 pandemic and respective restrictions might have impacted not only youth's mental health but also antidepressant prescribing. Our aim was to systematically investigate changes in antidepressant utilization during the pandemic compared to pre-pandemic periods in European young persons.

Methods: This systematic review was registered in PROSPERO (CRD42024559951). Observational studies with ≥ 100 European young persons (0-24 years) reporting prevalence or incidence data in antidepressant utilization before and during the pandemic (2018/2019 vs. 2021/2022) were included and percentage changes between two time periods calculated. MEDLINE (via PubMed), PsycINFO, and EMBASE were searched from January 1, 2021 to July 3, 2024 and supplemented by citation searching. Study quality was assessed using the Joanna Briggs Institute's tool.

Findings: We screened 4,416 records for eligibility and included eight studies covering data from Austria, Denmark, Finland, France, Italy, Norway, Spain, and Sweden (n = 4 from Nordic countries). The number of included young persons ranged from 1071 to 3,455,521 and all studies used secondary data, mostly from registries. All studies showed a relative increase in overall antidepressant use during the COVID-19 pandemic, with variability between countries ranging from 23 to 52%. Antidepressant utilization showed higher increases in adolescents (n = 3 studies) and females (n = 3 studies). Selective serotonin reuptake inhibitors were more common (73.9-90.9%; n = 3 studies) than other antidepressant classes.

Interpretation: During the COVID-19 pandemic, antidepressant utilization in young persons increased modestly in all studied European countries. This increase may mirror the surge in mental health problems in young persons during the pandemic, but may also reflect altered patterns of mental health services availability.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
12.80
自引率
4.70%
发文量
186
审稿时长
6-12 weeks
期刊介绍: European Child and Adolescent Psychiatry is Europe''s only peer-reviewed journal entirely devoted to child and adolescent psychiatry. It aims to further a broad understanding of psychopathology in children and adolescents. Empirical research is its foundation, and clinical relevance is its hallmark. European Child and Adolescent Psychiatry welcomes in particular papers covering neuropsychiatry, cognitive neuroscience, genetics, neuroimaging, pharmacology, and related fields of interest. Contributions are encouraged from all around the world.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信